Uncovering Symptom Progression History from Disease Registry Data with Application to Young Cystic Fibrosis Patients

被引:3
|
作者
Yan, Jun [1 ,2 ]
Cheng, Yu [3 ,4 ]
Fine, Jason P. [5 ]
Lai, HuiChuan J. [6 ,7 ]
机构
[1] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
[2] Univ Connecticut, Publ Hlth Res Inst, Storrs, CT 06269 USA
[3] Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA
[5] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[6] Univ Wisconsin, Dept Nutr Sci, Dept Biostat & Med Informat, Madison, WI 53706 USA
[7] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA
基金
美国国家科学基金会;
关键词
Generalized linear model; Lung infection; Newborn screening and diagnosis; Prevalence: Pseudomonas aeruginosa; Varying coefficient; PSEUDOMONAS-AERUGINOSA INFECTION; REGRESSION; SURVIVAL; PREVALENCE; COLONIZATION; RECURRENT;
D O I
10.1111/j.1541-0420.2009.01288.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The growing availability of various disease registry data has brought precious opportunities to epidemiologists to understand the natural history of the registered diseases. It also presents challenges to the traditional data analysis techniques because of complicated censoring/truncation schemes and temporal dynamics of covariate influences. In a case study of the Cystic Fibrosis Foundation Patient Registry data, we propose analyses of progressive symptoms using temporal process regressions, as an alternative to the commonly employed proportional hazards models. Two endpoints are considered, the prevalence of ever positive and currently positive for Pseudomonas aeruginosa. (PA) infection in the lungs, which capture different aspect of the disease process. The analysis of ever PA positive via, a time-varying coefficient model demonstrates the lack of fit, as well as the potential loss of information, in the standard proportional hazards analysis. The analysis of currently PA positive yields results that are clinically meaningful and have not previously been reported in the cystic fibrosis literature. Our analyses demonstrate that prenatal/neonatal screening results in lower prevalence of PA infection compared to traditional diagnosis via, signs and symptoms, but this benefit attenuates with age. Calendar years of diagnosis also affect the risk of PA infection; patients diagnosed in more recent cohort show higher prevalence of ever PA positive but lower prevalence of currently PA positive.
引用
收藏
页码:594 / 602
页数:9
相关论文
共 50 条
  • [31] Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry
    Szentpetery, Sylvia
    Fernandez, Gabriela S.
    Schechter, Michael S.
    Jain, Raksha
    Flume, Patrick A.
    Fink, Aliza K.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) : 777 - 783
  • [32] The Diagnosis of Cystic Fibrosis in Adult Age. Data from the Italian Registry
    Padoan, Rita
    Quattrucci, Serena
    Amato, Annalisa
    Carnovale, Vincenzo
    Salvatore, Donatello
    Salvatore, Marco
    Campagna, Giuseppe
    DIAGNOSTICS, 2021, 11 (02)
  • [33] Dornase alfa is well tolerated: Data from the Epidemiologic Registry of Cystic Fibrosis
    McKenzie, S. G.
    Chowdhury, S.
    Strandvik, B.
    Hodson, M. E.
    PEDIATRIC PULMONOLOGY, 2007, 42 (10) : 928 - 937
  • [34] Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry
    Zahav, Meir Mei
    Orenti, Annalisa
    Jung, Andreas
    Hatziagorou, Elpis
    Olesen, Hanne Vebert
    Kerem, Eitan
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (02) : 234 - 247
  • [35] Clinical Characteristics and Disease Burden in Patients with Cystic Fibrosis with Residual Function Mutations in the US Cystic Fibrosis Foundation Patient Registry
    Le Camus, C.
    Wu, R.
    Elbert, A.
    Fink, A.
    Bessonova, L.
    Suthoff, E.
    Schechter, M. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry
    Wanner, Christoph
    Oliveira, Joao P.
    Ortiz, Alberto
    Mauer, Michael
    Germain, Dominique P.
    Linthorst, Gabor E.
    Serra, Andreas L.
    Marodi, Laszlo
    Mignani, Renzo
    Cianciaruso, Bruno
    Vujkovac, Bojan
    Lemay, Roberta
    Beitner-Johnson, Dana
    Waldek, Stephen
    Warnock, David G.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12): : 2220 - 2228
  • [37] Upper Airway Findings and Markers of Lung Disease Progression in Patients with Cystic Fibrosis
    Steffen, Luciane Mazzini
    Pezzin, Luise Sgarabotto
    Sulis, Natassia
    Steffen, Nedio
    Pinto, Leonardo Araujo
    INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2020, 24 (04) : E434 - E437
  • [38] Predictors of sinonasal disease onset, progression, and severity in pediatric cystic fibrosis patients*
    Weinstock, Michael S.
    Shaffer, Amber D.
    Stapleton, Amanda L.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 42 (05)
  • [39] Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry
    Hatziagorou, Elpis
    Orenti, Steffen Fieuws Annalisa
    Naehrlich, Lutz
    Krivec, Uros
    Mei-Zahav, Meir
    Jung, Andreas
    De Boeck, Kris
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [40] Influence of a positive Family History on the Disease Progression in Patients with Type II Diabetes mellitus: Data from the Tyrolean Diabetes Registry
    Plattner, Clemens
    Pfeifer, Bernhard
    Leo, Marco
    Delmarko, Irmgard
    Sourij, Harald
    Kaser, Susanne
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 221 - 222